#161075

Anti-pancreatic duct cell marker Monoclonal Antibody (HPd3)

Cat. #161075

Anti-pancreatic duct cell marker Monoclonal Antibody (HPd3)

Cat. #: 161075

Sub-type: Primary antibody

Availability: 3-4 weeks

Class: Monoclonal

Application: FACS, IF (if frozen)

Reactivity: Human

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Markus Grompe, Philip Streeter, Craig Dorrell, Cherrie Abraham, Kelsea Shoop

Institute: Oregon Health & Science University

Primary Citation: Dorell et al. Stem Cell Res. 2008 Sep;1(3):183-94. PMID: 19383399

Tool Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-pancreatic duct cell marker Monoclonal Antibody (HPd3)
  • Alternate name: DHIC5-4D9
  • Cancer type filter: Pancreatic cancer
  • Cancers detailed: Digestive/Gastrointestinal Cancer - Pancreas
  • Research fields: Tags and cell markers
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Reactivity: Human
  • Host: Mouse
  • Application: FACS, IF (if frozen)
  • Description: Labels pancreatic duct cells (surface marker)
  • Immunogen: Human pancreatic islets
  • Isotype: IgM

Applications

  • Application: FACS, IF (if frozen)

Handling

  • Storage buffer: DMEM+10% FCS or Medium E (SCT)
  • Storage conditions: 4° C
  • Shipping conditions: Dry ice

References

  • Dorell et al. Stem Cell Res. 2008 Sep
  • 1(3):183-94. PMID: 19383399

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.